mercatusdata

AbbVie (ABBV): RSI, moving averages, 52-week range · daily

On 2026-10-16, AbbVie (ABBV) closed at 285.42 USD, up 0.71% on the day. At the 2026-10-16 close, AbbVie (ABBV) traded at 94.1% of its 52-week range. At the 2026-10-16 close, AbbVie (ABBV) had an RSI(14) of 71.06, in the 92nd percentile of its history since 2013. Its 20-day return of +8.13% is in the 85th percentile of its history since 2013. RSI above 70 is conventionally termed overbought. The RSI(14) of AbbVie (ABBV) last entered the overbought zone today (2026-10-16) and the oversold zone 211 days ago (2026-03-19). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-16 close, the 20/50/200-day moving averages of AbbVie (ABBV) were 269.93 / 262.45 / 233.95 USD, with price +5.74% / +8.75% / +22.00% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-16 close, the 52-week range of AbbVie (ABBV) was 190.75–291.4 USD; it closed 2.05% below the high (0.9× its typical daily range) and 49.63% above the low (14.8× its typical daily range). The high was set 1 day ago (2026-10-15) and the low 170 days ago (2026-04-29). At the 2026-10-16 close, AbbVie (ABBV) was 2.05% below its all-time intraday high of 291.4 USD, set 1 day ago (2026-10-15). Its 20-day volatility is 1.211% daily, in the 37th percentile of its history since 2013. Its daily realised volatility is 2.122% over 5 days, 1.211% over 20 days, 1.365% over 60 days and 1.621% over 120 days. Annualised, these are 33.7%, 19.2%, 21.7% and 25.7% respectively. Its 14-day average true range (ATR) is 6.41 USD, 2.25% of price. It has returned +3.24% (83rd percentile since 2013) over 5 days, +8.60% (95th) over 10 days, +8.13% (85th) over 20 days, +11.09% (73rd) over 60 days, +44.60% (98th) over 120 days and +26.17% (71st) over 252 days. Against the S&P 500, its weekly returns show a beta of -0.72 and a correlation of -0.31 over 52 weeks; over 26 weeks, a beta of -1.72 and a correlation of -0.54. Relative to the S&P 500, it has returned +5.18% (5-day), +9.42% (10-day), +8.01% (20-day), +7.70% (60-day) and +11.35% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.12 over 52 weeks and -0.06 over 26 weeks. Next earnings are scheduled for 2026-10-30.

Figures reflect the official regular-session close for 2026-10-16.

=== ABBVIE (ABBV)  (USD) ===
  price & change   (as of 2026-10-16, prior 2026-10-15)
    close       285.42
    change      +2.02  (+0.713%)
    vs market   S&P 500 -1.09% · Nasdaq 100 -2.50% (same day)
    listing     Exchange: NYSE, Currency: USD
  range            (as of 2026-10-16)
    range       3.68
    close pos   66.8% of range
  moving averages  (as of 2026-10-16)
     20d MA     269.93   price above by +5.74%
     50d MA     262.45   price above by +8.75%
    200d MA     233.95   price above by +22.00%
    200d MA slope  +1.89% over 20 sessions (rising)
    price > all MAs
    stack: 20d > 50d > 200d
    20d MA last crossed above 50d MA: 2026-05-27   (142d ago)
    20d MA last crossed above 200d MA: 2026-06-22   (116d ago)
    50d MA last crossed above 200d MA: 2026-07-09   (99d ago)
  volatility       (as of 2026-10-16)
    20d stdev   1.211% daily ≈ 19.2% annualised (×√252)   (37th pct of own history, since 2013 (3449 obs))
      5d vol     2.122% daily ≈ 33.7% annualised (×√252)   (84th pct of own history, since 2013 (3464 obs))
     60d vol     1.365% daily ≈ 21.7% annualised (×√252)   (37th pct of own history, since 2013 (3409 obs))
    120d vol     1.621% daily ≈ 25.7% annualised (×√252)   (58th pct of own history, since 2013 (3349 obs))
    vs easing-2024 avg  0.76× (1.211% vs 1.602% era avg)
  ATR              (as of 2026-10-16)
    ATR(14)    6.41
    ATR%        2.25%   (60th pct of own history, since 2013 (3455 obs))
    range/ATR   57.4%
  relative volume  (as of 2026-10-16)
    RVOL        1.16x  (today vs prior 20-day average, excl. today)
    pctile      77th pct of own history, since 2013 (3449 obs)
    avg vol 63d 4,851,603  (≈3-month average daily share volume)
  52-week range    (as of 2026-10-16)
    high        291.40   (-2.05% from high)   [2026-10-15, 1d ago]
    low         190.75   (+49.63% from low)   [2026-04-29, 170d ago]
    drawdown    -2.05% from all-time intraday high, 1d ago (2026-10-15)
    max drawdown (10-year, close-basis) -48.88% (2018-01-26 123.21 -> 2019-08-15 62.98, 566d peak-to-trough); recovered 2021-12-09 (847d after trough)
  momentum         (as of 2026-10-16)
    RSI(14)     71.06   (92nd pct of own history, since 2013 (3455 obs))
    last overbought   0d ago (2026-10-16)
    last oversold   211d ago (2026-03-19)
  MACD             (as of 2026-10-16)
    MACD(12,26,9)   +6.04 (above signal)   signal +4.35   hist +1.69
  returns          (as of 2026-10-16)
      5d return  +3.24%   from 276.47 on 2026-10-09   (83rd pct of own history, since 2013 (3464 obs))
     10d return  +8.60%   from 262.82 on 2026-10-02   (95th pct of own history, since 2013 (3459 obs))
     20d return  +8.13%   from 263.96 on 2026-09-18   (85th pct of own history, since 2013 (3449 obs))
     60d return  +11.09%   from 256.92 on 2026-07-23   (73rd pct of own history, since 2013 (3409 obs))
    120d return  +44.60%   from 197.38 on 2026-04-27   (98th pct of own history, since 2013 (3349 obs))
    252d return  +26.17%   from 226.22 on 2025-10-15   (71st pct of own history, since 2013 (3217 obs))
    YTD return  +24.92%   from 228.49 on 2025-12-31
  volatility by rate-era
    ZIRP (2009–2015)         1.73%   (from 2013-01-02)
    tightening (2015–2018)   1.75%
    ZIRP (2019–2021)         1.77%
    tightening (2022–2023)   1.33%
    easing (2024– )          1.60%
  real-yield sensitivity (weekly returns vs weekly Δ in 10Y TIPS real yield, DFII10)  (as of 2026-10-15)
    vs real yield (Δ) -0.06 (26w)
    vs real yield (Δ) -0.12 (52w)
  S&P 500 market factor (weekly returns)  (as of 2026-10-16)
    vs S&P 500  beta -1.72  corr -0.54  (26w)
    vs S&P 500  beta -0.72  corr -0.31  (52w)
    vs S&P 500  +5.18% rel (5d return)
    vs S&P 500  +9.42% rel (10d return)
    vs S&P 500  +8.01% rel (20d return)
    vs S&P 500  +7.70% rel (60d return)
    vs S&P 500  +11.35% rel (252d return)
    vs Nasdaq 100  beta -1.00  corr -0.62  (26w)
    vs Nasdaq 100  beta -0.64  corr -0.44  (52w)
    vs Nasdaq 100  +8.76% rel (5d return)
    vs Nasdaq 100  +13.91% rel (10d return)
    vs Nasdaq 100  +9.74% rel (20d return)
    vs Nasdaq 100  +8.51% rel (60d return)
    vs Nasdaq 100  +8.31% rel (252d return)
    vs XLV (Health Care)  beta +1.50  corr +0.83  (26w)
    vs XLV (Health Care)  beta +1.21  corr +0.71  (52w)
    vs XLV  -0.22% rel (5d return)
    vs XLV  +2.26% rel (10d return)
    vs XLV  +3.19% rel (20d return)
    vs XLV  +1.63% rel (60d return)
    vs XLV  +2.21% rel (252d return)
  earnings horizon
    next earnings 2026-10-30  (14 days)